
In Episode 2, Part 4, Cheryl Allen, Nick Calla and Rena Goins discuss how the industry is building channels around complex products.
Barbara Morgan examines how the BIOSECURE act will affect supply chains.
The US pharmaceutical industry is entering a new phase of supply chain transformation.






